CPhI South East Asia strengthens ASEAN integration by opening Thailand edition in 2019

9 Apr 2018

The event will annually switch between Indonesia and Thailand to cater to attendees that were previously unable to participate.

From 2019 onwards CPhI South East Asia – organised by UBM – will alternate its annual location between the region’s two largest pharma economies, Indonesia and Thailand.

CPhI South East Asia strengthens ASEAN integration by opening Thailand edition in 2019

In 2019, CPhI South East Asia will take place at the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand (12-14 March) before returning to Jakarta International Expo (JIExpo) in Indonesia in 2020 (4-6 March). CPhI South East Asia’s strategic move to Thailand will further strengthen the event’s appeal within the region. Organizers anticipate a significant growth in new visitors from more diverse locations with the new venue, catering to attendees that were previously unable to participate. The event’s first visit to Thailand comes at a significant time for the country, as pharma sales are expected to grow by 8.4% in 2019, with multinational corporations increasingly looking to partner with local contract manufacturers to expedite and streamline market access. According to data from BMI Research, by 2021 the pharmaceutical market is forecast to reach a value of THB 209.7 billion (USD 6.3 billion), experiencing a compound annual growth rate (CAGR) of 5.4% in local currency terms and 6.8% in US dollar terms. Over the extended forecast period, medicine sales will experience a 10-year CAGR of 5.5% and 6.3% in local currency and US dollar terms respectively, reaching THB 275.2 billion (USD 8.4 billion) by 2026. “This is very much a natural progression for the CPhI South East Asia and the region, opening even greater opportunities to meet new partners and expand pharma sales. Collectively, these two countries account for over 50% of the region’s sales. Our research shows there is a large opportunity, in particular, for contract services and ingredients, and by annually switching location we will increase the depth and quality of regional partners available. Furthermore, we will attract a wider perspective of visitors, all of which will ultimately accelerate ASEAN’s Pharmaceutical harmonisation and cross-border collaborations,” added Chris Kilbee, Group Director, Pharma at UBM. According to PhRMA's Special 301 submission for 2017, Thailand was once again designated as a 'Priority Watch List Country'. Notably, only India and Indonesia share this status in the entire Asia Pacific region. In addition, the country is set to benefit from amendments to the Patents Act 2017 – which enables an expedited Thai patent application for companies with existing patents from Australia, China, the EU, Japan, South Korea and the US – further cementing international interest. Kilbee added: “The 2019 edition will open increased international opportunities for domestic manufacturers in Thailand that have not yet had the capacity or partners to expand regionally. Plus, with MNCs looking to capitalise on regulatory changes this year, we expect many new international attendees” CPhI South East Asia, which just celebrated its 7th year, will co-locate in 2019 with FDF, ICSE, P-MEC, InnoPack, and the returning LABworld South East Asia – following a hugely successful opening year. UBM forecasts the inaugural edition in Bangkok will host more than 6000 attendees and 270 exhibitors. Executives will come from across the region’s fastest growing industries including pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing, as well as nutraceutical companies and laboratory specialists – facilitating a collective environment that is designed to stimulate the next stage in the ASEAN pharma expansion.

Read More

Related news

CPhI Worldwide opens entries for 15th Annual Pharma Awards

CPhI Worldwide opens entries for 15th Annual Pharma Awards

5 Jul 2018

Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.

Read more 
I Holland woos exhibition visitors with new tabletting technologies

I Holland woos exhibition visitors with new tabletting technologies

28 Jun 2018

Company's Wear Indicator Layer attracts the most attention.

Read more 
Ingredients to improve bioprocess manufacturing efficiency

Ingredients to improve bioprocess manufacturing efficiency

27 Jun 2018

Experts warn bio industry needs to do more to create a sustainable pipeline of talent.

Read more 
Collaboration facilitates continuous manufacturing

Collaboration facilitates continuous manufacturing

14 Jun 2018

Companies working together to help the pharmaceutical industry overcome the different challenges involved in adopting continuous manufacturing.

Read more 
Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital

Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital

12 Jun 2018

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences.

Read more 
Innovative coating process for tablet manufacturers

Innovative coating process for tablet manufacturers

7 Jun 2018

The Wear Indicator Layer is expected to have a "huge impact" on customers' production.

Read more 
New finished product manufacturing hub in the Middle East

New finished product manufacturing hub in the Middle East

30 May 2018

Forgotten markets of Africa and Arabia to see increased growth fuelled by international and domestic partnerships and imported APIs.

Read more 
Characterisation technologies for pharma manufacturers

Characterisation technologies for pharma manufacturers

25 May 2018

Testa Anayltical to discuss their latest developments and application advances in Light Scattering technology, GPC/SEC instrumentation and Zeta potential measurement.

Read more 
The shortest way from the lab to continuous production

The shortest way from the lab to continuous production

24 May 2018

Bosch's new Xelum R&D for continuous production of oral solid dosage forms ensures a short time-to-market and optimum dosing of APIs.

Read more 
Internationalisation and regulatory reform driving growth and investment at CPhI China

Internationalisation and regulatory reform driving growth and investment at CPhI China

22 May 2018

2018 event prepares for surge in international attendees as MAH nears national rollout.

Read more